Literature DB >> 1284126

Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.

A R Mackay1, M Ballin, M D Pelina, A R Farina, A M Nason, J L Hartzler, U P Thorgeirsson.   

Abstract

The effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and the cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) on matrix metalloproteinases (MMP) and metalloproteinase inhibitors was studied in a variety of human cell lines. Expression of the mammalian collagenase (MMP-1), 72-kD gelatinase/type IV collagenase (MMP-2), stromelysin (MMP-3), 92-kD gelatinase/type IV collagenase (MMP-9), and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) was assessed by zymography and Northern blot analysis. MMP-2 and TIMP-2 activities were refractory to TPA, IL-1 and TNF-alpha treatment in most of the cell lines. In contrast, MMP-3, MMP-9 and TIMP-1 activities were markedly stimulated by TPA in most of the tumor cell lines and human umbilical vein endothelial cells (HUVEC), whereas the fibroblast lines were minimally stimulated or unresponsive to TPA. The MMP-3, MMP-9 and TIMP-1 stimulation in response to IL-1 and TNF-alpha treatment was detected in some of the tumor cell lines and HUVEC. The increase in activity was less marked than in TPA. A breast carcinoma cell line, MDA-MB-231, which did not express MMP-2, had high expression of MMP-3 and MMP-9 which were unaffected by TPA and cytokine treatment. Northern blot analysis of MMP and TIMP mRNA expression reflected the zymogram findings for most of the cell lines. TPA-mediated stimulation of MMP-1 was similar to that of MMP-3 and MMP-9. Exceptions were the fibroblast cell lines which showed either a much more marked mRNA response of MMP-9 to TPA than observed at protein level, or a high constitutive MMP-9 mRNA when MMP-9 activity was not detectable by zymography. TPA-mediated stimulation of MMP-9 and TIMP-1 activity was blocked by staurosporine, an inhibitor of protein kinase C (PKC). A non-PKC-activating phorbol ester, 4 alpha-phorbol-12,13-didecanoate, did not stimulate MMP-9 and TIMP-1 activity. TPA treatment caused the increased expression of c-fos containing AP-1-specific binding activity in selected tumor cell lines. This activity was maximal at 6 h. An association was observed between AP-1 binding activity and increased expression of MMP-1, MMP-3 and MMP-9, which possess TPA-responsive elements (TRE). TPA-sensitive MMPs and TIMP-1 were variably stimulated by biologically relevant cytokines, such as IL-1 and TNF-alpha.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284126

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  45 in total

1.  Expression and distribution of matrix metalloproteinases and their inhibitors in the human iris and ciliary body.

Authors:  J Lan; R K Kumar; N Di Girolamo; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns.

Authors:  L J Kaufman; C P Brangwynne; K E Kasza; E Filippidi; V D Gordon; T S Deisboeck; D A Weitz
Journal:  Biophys J       Date:  2005-04-22       Impact factor: 4.033

3.  Keratinocyte-releasable factors increased the expression of MMP1 and MMP3 in co-cultured fibroblasts under both 2D and 3D culture conditions.

Authors:  Min Li; Alireza Moeen Rezakhanlou; Claudia Chavez-Munoz; Amy Lai; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2009-06-12       Impact factor: 3.396

4.  Interleukin-1-mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo.

Authors:  Claudia Orelio; Esther Haak; Marian Peeters; Elaine Dzierzak
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

5.  Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.

Authors:  A Ladányi; J O Nagy; A Jeney; J Tímár
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.

Authors:  H Kawamoto; K Kawamoto; T Mizoue; T Uozumi; K Arita; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.

Authors:  C K Lindsay; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

9.  Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Cell Int       Date:  2010-03-24       Impact factor: 5.722

10.  Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.

Authors:  Jessica Bauer; Gerhard Liebisch; Claudia Hofmann; Christian Huy; Gerd Schmitz; Florian Obermeier; Jürgen Bock
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.